ILLUMINA, INC.
SAN DIEGO, CA

Illumina, Inc., founded in November 2010 with its global headquarters at 5200 Illumina Way, San Diego, CA, is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company's mission-critical goal is to apply innovative technologies to the study of genetics, enabling groundbreaking advancements in life sciences research, translational genomics, consumer genomics, and molecular diagnostics. Illumina operates at the intersection of biology and technology and aspires to advance human health through personalized medicine. Their leading-edge sequencing and array technologies are vital in realizing studies previously unimaginable, propelling significant developments in disease research, drug development, and genomics. The company is committed to delivering innovative, flexible, and scalable solutions tailored to meet diverse customer needs. The firm, which is publicly listed with the status of Florida.Models.Dos.FloridaCompanyStatus type OFC, engages actively within its communities through outreach programs that connect employees to initiatives across various focus areas. This involvement underscores Illumina's dedication to making a meaningful impact on society while fostering collaborations and rapid solution delivery. Illumina’s portfolio includes an extensive range of sequencing and array platforms that address customer needs spanning basic research to clinical applications, including cancer diagnostics. Noteworthy is the company's role in helping transform genomics from science fiction to mainstream reality through its technological capabilities that enable quick, accurate genomic analyses for personalized treatment plans and other scientific applications. The leadership team includes Jacob Thaysen as President, with Joydeep Goswami as a senior executive, along with Frances Arnold among its directors. The company's continuous commitment to quality and innovation is reflected in its recent annual report dated April 17, 2024. For more information about Illumina or their cutting-edge solutions in genomics technology, visit their website at illumina.com.